KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Takeda Pharmaceutical (TAK) Interest Coverage Ratio (2017 - 2025)

Historic Interest Coverage Ratio for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to 1.37.

  • Takeda Pharmaceutical's Interest Coverage Ratio rose 6580.67% to 1.37 in Q4 2025 from the same period last year, while for Dec 2025 it was 3.1, marking a year-over-year decrease of 13205.22%. This contributed to the annual value of 1.63 for FY2025, which is 6748.52% up from last year.
  • Takeda Pharmaceutical's Interest Coverage Ratio amounted to 1.37 in Q4 2025, which was up 6580.67% from 3.3 recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Interest Coverage Ratio ranged from a high of 0.8 in Q1 2022 and a low of 6.58 during Q3 2024
  • Over the past 5 years, Takeda Pharmaceutical's median Interest Coverage Ratio value was 2.81 (recorded in 2023), while the average stood at 2.78.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first soared by 12470.67% in 2022, then crashed by 1418853.47% in 2025.
  • Takeda Pharmaceutical's Interest Coverage Ratio (Quarter) stood at 2.49 in 2021, then increased by 26.1% to 1.84 in 2022, then crashed by 207.75% to 5.67 in 2023, then rose by 29.59% to 3.99 in 2024, then skyrocketed by 65.81% to 1.37 in 2025.
  • Its Interest Coverage Ratio stands at 1.37 for Q4 2025, versus 3.3 for Q3 2025 and 4.2 for Q2 2025.